Breaking News

Aragen Building $30M Biomanufacturing Site in India

Spanning nearly 160,000 square meters, it includes process development labs and multiple GMP manufacturing suites with supporting functions.

Aragen, a contract research development and manufacturing organization (CRDMO) for small molecules and biologics, is setting up a new biologics manufacturing facility in Bangalore, India. The facility is part of a $30 million investment, spanning nearly 160,000 square meters, and includes process development labs and multiple GMP manufacturing suites with supporting functions like quality control labs (analytical and microbiology). The manufacturing suites will be equipped for intensified pro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters